Camilla K. Lemvigh

University of Copenhagen — Denmark

Medicine · Health Sciences

8h-index589citations44works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(33), Acute Lymphoblastic Leukemia research(21), Advanced Breast Cancer Therapies(10), Immunodeficiency and Autoimmune Disorders(6), Chronic Myeloid Leukemia Treatments(4)

Publications44 total

Heterogeneity of the intestinal mononuclear phagocyte compartment in health and inflammatory bowel disease
Science Immunology·2025
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
Frontiers in Immunology·2025· 5 citedOpen Access
439 Exploring microbial antigen cross-reactivity in tumor-infiltrating lymphocytes after adoptive cell transfer in metastatic melanoma
Regular and Young Investigator Award Abstracts·2024Open Access
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
Cancer Cell·2023· 70 citedOpen Access
Figure S5 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Supplementary Figures and Legends from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S2 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Data from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S2 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S4 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S7 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S2 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S7 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Data from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S4 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S3 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Catherine J. Wu(36), Donna Neuberg(35), Kenneth J. Livak(34), Shuqiang Li(32), Laura Z. Rassenti(30), Thomas J. Kipps(30), Neil E. Kay(30), Jennifer R. Brown(30), Noelia Purroy(29), Stacey M. Fernandes(28), Helene Kretzmer(25), Anat Biran(25), Kendell Clement(25), Michaela Gruber(25), Hongcang Gu(25), Arman W. Mohammad(25), Connie Lesnick(25), Susan L. Slager(25), Esteban Braggio(25), Tait D. Shanafelt(25)